Acadian Asset Management
CRBU icon

Acadian Asset Management’s Caribou Biosciences CRBU Stock Holding History

Acadian Asset Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.12M Buy
1,774,474
+849,435
+92% +$1.68M ﹤0.01% 937
2026
Q1 		$1.75M Buy
925,039
+865,317
+1,449% +$1.49M ﹤0.01% 996
2025
Q4 		$94K Buy
+59,722
New +$125K ﹤0.01% 1684
2025
Q2 		– Sell
-67,725
Closed -$61K – 1684
2025
Q1 		$61K Buy
+67,725
New +$88K ﹤0.01% 1414
2024
Q2 		– Sell
-156,238
Closed -$802K – 1770
2024
Q1 		$802K Buy
156,238
+11,921
+8% +$73.5K ﹤0.01% 904
2023
Q4 		$826K Buy
+144,317
New +$713K ﹤0.01% 910

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Acadian Asset Management's CRBU Position: Q2 2026 in Review

Acadian Asset Management increased its Caribou Biosciences (CRBU) stake by 92% in Q2 2026, buying an estimated $1.68M and bringing the position to 1,774,474 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #937.

Acadian Asset Management first reported a position in CRBU in Q4 2023 and has held it in 6 quarters since. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Acadian Asset Management held 1,774,474 shares of Caribou Biosciences worth $3.12M as of Q2 2026.
  • Acadian Asset Management bought 849,435 Caribou Biosciences shares in Q2 2026, an estimated $1.68M.
  • Caribou Biosciences made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #937 holding.
  • Acadian Asset Management first reported a position in Caribou Biosciences in Q4 2023 and has held it in 6 quarters since.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.